nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—pancreatic cancer	0.363	1	CbGaD
Mefenamic acid—AKR1C3—Doxorubicin—pancreatic cancer	0.239	0.583	CbGbCtD
Mefenamic acid—CYP2C8—Tamoxifen—pancreatic cancer	0.0451	0.11	CbGbCtD
Mefenamic acid—CYP2C8—Erlotinib—pancreatic cancer	0.0383	0.0934	CbGbCtD
Mefenamic acid—CYP2C8—Fluorouracil—pancreatic cancer	0.0332	0.0809	CbGbCtD
Mefenamic acid—CYP2C9—Tamoxifen—pancreatic cancer	0.0314	0.0766	CbGbCtD
Mefenamic acid—CYP2C9—Fluorouracil—pancreatic cancer	0.0232	0.0564	CbGbCtD
Mefenamic acid—Acetylsalicylic acid—NFKBIA—pancreatic cancer	0.0023	0.302	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—TP53—pancreatic cancer	0.00102	0.134	CrCbGaD
Mefenamic acid—Floctafenine—PTGS2—pancreatic cancer	0.000523	0.0687	CrCbGaD
Mefenamic acid—Diclofenac—CXCL8—pancreatic cancer	0.000503	0.066	CrCbGaD
Mefenamic acid—Ketoprofen—CXCL8—pancreatic cancer	0.000446	0.0585	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—pancreatic cancer	0.000337	0.0443	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—pancreatic cancer	0.000337	0.0443	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—pancreatic cancer	0.000321	0.0421	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—pancreatic cancer	0.000301	0.0394	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—pancreatic cancer	0.000267	0.035	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—pancreatic cancer	0.000263	0.0345	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—pancreatic cancer	0.00022	0.0289	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—pancreatic cancer	0.000199	0.0261	CrCbGaD
Mefenamic acid—Pruritus—Sunitinib—pancreatic cancer	0.000198	0.001	CcSEcCtD
Mefenamic acid—Constipation—Irinotecan—pancreatic cancer	0.000197	0.000996	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000197	0.000995	CcSEcCtD
Mefenamic acid—Dyspnoea—Fluorouracil—pancreatic cancer	0.000197	0.000995	CcSEcCtD
Mefenamic acid—Mental disorder—Docetaxel—pancreatic cancer	0.000197	0.000993	CcSEcCtD
Mefenamic acid—Somnolence—Fluorouracil—pancreatic cancer	0.000196	0.000992	CcSEcCtD
Mefenamic acid—Decreased appetite—Gemcitabine—pancreatic cancer	0.000195	0.000986	CcSEcCtD
Mefenamic acid—Dyspepsia—Fluorouracil—pancreatic cancer	0.000194	0.000982	CcSEcCtD
Mefenamic acid—Nausea—Tamoxifen—pancreatic cancer	0.000194	0.000981	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000194	0.00098	CcSEcCtD
Mefenamic acid—Gastritis—Epirubicin—pancreatic cancer	0.000194	0.000978	CcSEcCtD
Mefenamic acid—Constipation—Gemcitabine—pancreatic cancer	0.000192	0.00097	CcSEcCtD
Mefenamic acid—Nausea—Erlotinib—pancreatic cancer	0.000192	0.00097	CcSEcCtD
Mefenamic acid—Decreased appetite—Fluorouracil—pancreatic cancer	0.000192	0.00097	CcSEcCtD
Mefenamic acid—Diarrhoea—Sunitinib—pancreatic cancer	0.000191	0.000968	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000191	0.000963	CcSEcCtD
Mefenamic acid—Feeling abnormal—Irinotecan—pancreatic cancer	0.00019	0.00096	CcSEcCtD
Mefenamic acid—Asthma—Epirubicin—pancreatic cancer	0.000189	0.000955	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000189	0.000953	CcSEcCtD
Mefenamic acid—Eosinophilia—Epirubicin—pancreatic cancer	0.000187	0.000946	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000187	0.000944	CcSEcCtD
Mefenamic acid—Pancreatitis—Epirubicin—pancreatic cancer	0.000185	0.000936	CcSEcCtD
Mefenamic acid—Dizziness—Sunitinib—pancreatic cancer	0.000185	0.000935	CcSEcCtD
Mefenamic acid—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000185	0.000935	CcSEcCtD
Mefenamic acid—Abdominal pain—Irinotecan—pancreatic cancer	0.000182	0.000921	CcSEcCtD
Mefenamic acid—Body temperature increased—Irinotecan—pancreatic cancer	0.000182	0.000921	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000182	0.000921	CcSEcCtD
Mefenamic acid—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000182	0.000919	CcSEcCtD
Mefenamic acid—Anaemia—Docetaxel—pancreatic cancer	0.00018	0.000912	CcSEcCtD
Mefenamic acid—Pancytopenia—Epirubicin—pancreatic cancer	0.00018	0.000907	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—pancreatic cancer	0.000179	0.000905	CcSEcCtD
Mefenamic acid—Vomiting—Sunitinib—pancreatic cancer	0.000178	0.000899	CcSEcCtD
Mefenamic acid—Body temperature increased—Gemcitabine—pancreatic cancer	0.000178	0.000897	CcSEcCtD
Mefenamic acid—Dysuria—Epirubicin—pancreatic cancer	0.000177	0.000893	CcSEcCtD
Mefenamic acid—Rash—Sunitinib—pancreatic cancer	0.000176	0.000892	CcSEcCtD
Mefenamic acid—Dermatitis—Sunitinib—pancreatic cancer	0.000176	0.000891	CcSEcCtD
Mefenamic acid—Urticaria—Fluorouracil—pancreatic cancer	0.000175	0.000886	CcSEcCtD
Mefenamic acid—Headache—Sunitinib—pancreatic cancer	0.000175	0.000886	CcSEcCtD
Mefenamic acid—Syncope—Docetaxel—pancreatic cancer	0.000175	0.000885	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—pancreatic cancer	0.000175	0.000884	CcSEcCtD
Mefenamic acid—Leukopenia—Docetaxel—pancreatic cancer	0.000175	0.000883	CcSEcCtD
Mefenamic acid—Body temperature increased—Fluorouracil—pancreatic cancer	0.000175	0.000882	CcSEcCtD
Mefenamic acid—Eosinophilia—Doxorubicin—pancreatic cancer	0.000173	0.000875	CcSEcCtD
Mefenamic acid—Palpitations—Docetaxel—pancreatic cancer	0.000173	0.000872	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000173	0.000872	CcSEcCtD
Mefenamic acid—Loss of consciousness—Docetaxel—pancreatic cancer	0.000172	0.000867	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—pancreatic cancer	0.000171	0.000866	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000171	0.000862	CcSEcCtD
Mefenamic acid—Pneumonia—Epirubicin—pancreatic cancer	0.00017	0.000857	CcSEcCtD
Mefenamic acid—Convulsion—Docetaxel—pancreatic cancer	0.000169	0.000855	CcSEcCtD
Mefenamic acid—Hypertension—Docetaxel—pancreatic cancer	0.000169	0.000852	CcSEcCtD
Mefenamic acid—Drowsiness—Epirubicin—pancreatic cancer	0.000169	0.000852	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000167	0.000844	CcSEcCtD
Mefenamic acid—Nausea—Sunitinib—pancreatic cancer	0.000166	0.00084	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—pancreatic cancer	0.000166	0.000839	CcSEcCtD
Mefenamic acid—Renal failure—Epirubicin—pancreatic cancer	0.000166	0.000837	CcSEcCtD
Mefenamic acid—Asthenia—Irinotecan—pancreatic cancer	0.000165	0.000836	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000165	0.000834	CcSEcCtD
Mefenamic acid—Stomatitis—Epirubicin—pancreatic cancer	0.000164	0.00083	CcSEcCtD
Mefenamic acid—Jaundice—Epirubicin—pancreatic cancer	0.000164	0.00083	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—pancreatic cancer	0.000164	0.0215	CrCbGaD
Mefenamic acid—Conjunctivitis—Epirubicin—pancreatic cancer	0.000164	0.000828	CcSEcCtD
Mefenamic acid—Dysuria—Doxorubicin—pancreatic cancer	0.000164	0.000826	CcSEcCtD
Mefenamic acid—Dry mouth—Docetaxel—pancreatic cancer	0.000163	0.000821	CcSEcCtD
Mefenamic acid—Asthenia—Gemcitabine—pancreatic cancer	0.000161	0.000814	CcSEcCtD
Mefenamic acid—Haematuria—Epirubicin—pancreatic cancer	0.000161	0.000812	CcSEcCtD
Mefenamic acid—Confusional state—Docetaxel—pancreatic cancer	0.000161	0.000812	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00016	0.000807	CcSEcCtD
Mefenamic acid—Oedema—Docetaxel—pancreatic cancer	0.000159	0.000805	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000159	0.000805	CcSEcCtD
Mefenamic acid—Pruritus—Gemcitabine—pancreatic cancer	0.000159	0.000803	CcSEcCtD
Mefenamic acid—Infection—Docetaxel—pancreatic cancer	0.000158	0.0008	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000158	0.000797	CcSEcCtD
Mefenamic acid—Diarrhoea—Irinotecan—pancreatic cancer	0.000158	0.000797	CcSEcCtD
Mefenamic acid—Agranulocytosis—Epirubicin—pancreatic cancer	0.000157	0.000795	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—pancreatic cancer	0.000157	0.000793	CcSEcCtD
Mefenamic acid—Shock—Docetaxel—pancreatic cancer	0.000157	0.000792	CcSEcCtD
Mefenamic acid—Pruritus—Fluorouracil—pancreatic cancer	0.000156	0.000789	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000156	0.000788	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—pancreatic cancer	0.000156	0.000788	CcSEcCtD
Mefenamic acid—Tachycardia—Docetaxel—pancreatic cancer	0.000156	0.000786	CcSEcCtD
Mefenamic acid—Skin disorder—Docetaxel—pancreatic cancer	0.000155	0.000782	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000155	0.000781	CcSEcCtD
Mefenamic acid—Diarrhoea—Gemcitabine—pancreatic cancer	0.000154	0.000776	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—pancreatic cancer	0.000153	0.000775	CcSEcCtD
Mefenamic acid—Dizziness—Irinotecan—pancreatic cancer	0.000152	0.00077	CcSEcCtD
Mefenamic acid—Haemoglobin—Epirubicin—pancreatic cancer	0.000152	0.000768	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—pancreatic cancer	0.000152	0.000768	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—pancreatic cancer	0.000152	0.000768	CcSEcCtD
Mefenamic acid—Anorexia—Docetaxel—pancreatic cancer	0.000152	0.000768	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000152	0.000766	CcSEcCtD
Mefenamic acid—Haemorrhage—Epirubicin—pancreatic cancer	0.000151	0.000764	CcSEcCtD
Mefenamic acid—Hepatitis—Epirubicin—pancreatic cancer	0.000151	0.000764	CcSEcCtD
Mefenamic acid—Diarrhoea—Fluorouracil—pancreatic cancer	0.000151	0.000763	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000149	0.000755	CcSEcCtD
Mefenamic acid—Hypotension—Docetaxel—pancreatic cancer	0.000149	0.000752	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—pancreatic cancer	0.000149	0.000751	CcSEcCtD
Mefenamic acid—Urethral disorder—Epirubicin—pancreatic cancer	0.000148	0.000749	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—pancreatic cancer	0.000147	0.0193	CrCbGaD
Mefenamic acid—Vomiting—Irinotecan—pancreatic cancer	0.000147	0.000741	CcSEcCtD
Mefenamic acid—Dizziness—Fluorouracil—pancreatic cancer	0.000146	0.000738	CcSEcCtD
Mefenamic acid—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000146	0.000735	CcSEcCtD
Mefenamic acid—Rash—Irinotecan—pancreatic cancer	0.000145	0.000734	CcSEcCtD
Mefenamic acid—Dermatitis—Irinotecan—pancreatic cancer	0.000145	0.000734	CcSEcCtD
Mefenamic acid—Headache—Irinotecan—pancreatic cancer	0.000144	0.00073	CcSEcCtD
Mefenamic acid—Insomnia—Docetaxel—pancreatic cancer	0.000144	0.000728	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—pancreatic cancer	0.000144	0.0189	CrCbGaD
Mefenamic acid—Paraesthesia—Docetaxel—pancreatic cancer	0.000143	0.000723	CcSEcCtD
Mefenamic acid—Erythema multiforme—Epirubicin—pancreatic cancer	0.000143	0.000723	CcSEcCtD
Mefenamic acid—Vomiting—Gemcitabine—pancreatic cancer	0.000143	0.000721	CcSEcCtD
Mefenamic acid—Dyspnoea—Docetaxel—pancreatic cancer	0.000142	0.000718	CcSEcCtD
Mefenamic acid—Somnolence—Docetaxel—pancreatic cancer	0.000142	0.000716	CcSEcCtD
Mefenamic acid—Rash—Gemcitabine—pancreatic cancer	0.000142	0.000715	CcSEcCtD
Mefenamic acid—Dermatitis—Gemcitabine—pancreatic cancer	0.000141	0.000715	CcSEcCtD
Mefenamic acid—Tinnitus—Epirubicin—pancreatic cancer	0.000141	0.000713	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—pancreatic cancer	0.000141	0.000711	CcSEcCtD
Mefenamic acid—Headache—Gemcitabine—pancreatic cancer	0.000141	0.000711	CcSEcCtD
Mefenamic acid—Vomiting—Fluorouracil—pancreatic cancer	0.00014	0.000709	CcSEcCtD
Mefenamic acid—Dyspepsia—Docetaxel—pancreatic cancer	0.00014	0.000709	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—pancreatic cancer	0.00014	0.000707	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—pancreatic cancer	0.00014	0.000707	CcSEcCtD
Mefenamic acid—Rash—Fluorouracil—pancreatic cancer	0.000139	0.000703	CcSEcCtD
Mefenamic acid—Dermatitis—Fluorouracil—pancreatic cancer	0.000139	0.000703	CcSEcCtD
Mefenamic acid—Decreased appetite—Docetaxel—pancreatic cancer	0.000139	0.0007	CcSEcCtD
Mefenamic acid—Headache—Fluorouracil—pancreatic cancer	0.000138	0.000699	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000138	0.000699	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000138	0.000695	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—pancreatic cancer	0.000137	0.000693	CcSEcCtD
Mefenamic acid—Nausea—Irinotecan—pancreatic cancer	0.000137	0.000692	CcSEcCtD
Mefenamic acid—Constipation—Docetaxel—pancreatic cancer	0.000136	0.000689	CcSEcCtD
Mefenamic acid—Arrhythmia—Epirubicin—pancreatic cancer	0.000135	0.000683	CcSEcCtD
Mefenamic acid—Alopecia—Epirubicin—pancreatic cancer	0.000134	0.000676	CcSEcCtD
Mefenamic acid—Nausea—Gemcitabine—pancreatic cancer	0.000133	0.000674	CcSEcCtD
Mefenamic acid—Mental disorder—Epirubicin—pancreatic cancer	0.000133	0.00067	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000132	0.000669	CcSEcCtD
Mefenamic acid—Feeling abnormal—Docetaxel—pancreatic cancer	0.000131	0.000664	CcSEcCtD
Mefenamic acid—Nausea—Fluorouracil—pancreatic cancer	0.000131	0.000663	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—pancreatic cancer	0.000131	0.000659	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00013	0.000658	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—pancreatic cancer	0.00013	0.0171	CrCbGaD
Mefenamic acid—Flatulence—Epirubicin—pancreatic cancer	0.00013	0.000656	CcSEcCtD
Mefenamic acid—Tension—Epirubicin—pancreatic cancer	0.000129	0.000653	CcSEcCtD
Mefenamic acid—Nervousness—Epirubicin—pancreatic cancer	0.000128	0.000646	CcSEcCtD
Mefenamic acid—Abdominal pain—Docetaxel—pancreatic cancer	0.000126	0.000637	CcSEcCtD
Mefenamic acid—Body temperature increased—Docetaxel—pancreatic cancer	0.000126	0.000637	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—pancreatic cancer	0.000125	0.000632	CcSEcCtD
Mefenamic acid—Vision blurred—Epirubicin—pancreatic cancer	0.000124	0.000627	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—pancreatic cancer	0.000124	0.000625	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—pancreatic cancer	0.000123	0.00062	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000122	0.000617	CcSEcCtD
Mefenamic acid—Anaemia—Epirubicin—pancreatic cancer	0.000122	0.000615	CcSEcCtD
Mefenamic acid—Flatulence—Doxorubicin—pancreatic cancer	0.00012	0.000607	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—pancreatic cancer	0.00012	0.000604	CcSEcCtD
Mefenamic acid—Malaise—Epirubicin—pancreatic cancer	0.000119	0.0006	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—pancreatic cancer	0.000118	0.000598	CcSEcCtD
Mefenamic acid—Vertigo—Epirubicin—pancreatic cancer	0.000118	0.000598	CcSEcCtD
Mefenamic acid—Syncope—Epirubicin—pancreatic cancer	0.000118	0.000597	CcSEcCtD
Mefenamic acid—Leukopenia—Epirubicin—pancreatic cancer	0.000118	0.000596	CcSEcCtD
Mefenamic acid—Palpitations—Epirubicin—pancreatic cancer	0.000116	0.000588	CcSEcCtD
Mefenamic acid—Loss of consciousness—Epirubicin—pancreatic cancer	0.000116	0.000585	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—pancreatic cancer	0.000115	0.00058	CcSEcCtD
Mefenamic acid—Asthenia—Docetaxel—pancreatic cancer	0.000114	0.000578	CcSEcCtD
Mefenamic acid—Convulsion—Epirubicin—pancreatic cancer	0.000114	0.000577	CcSEcCtD
Mefenamic acid—Hypertension—Epirubicin—pancreatic cancer	0.000114	0.000575	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000113	0.000571	CcSEcCtD
Mefenamic acid—Pruritus—Docetaxel—pancreatic cancer	0.000113	0.00057	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—pancreatic cancer	0.000113	0.000569	CcSEcCtD
Mefenamic acid—Anxiety—Epirubicin—pancreatic cancer	0.000112	0.000565	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000111	0.000563	CcSEcCtD
Mefenamic acid—Discomfort—Epirubicin—pancreatic cancer	0.000111	0.00056	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—pancreatic cancer	0.00011	0.000555	CcSEcCtD
Mefenamic acid—Dry mouth—Epirubicin—pancreatic cancer	0.00011	0.000554	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—pancreatic cancer	0.000109	0.000553	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—pancreatic cancer	0.000109	0.000552	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—pancreatic cancer	0.000109	0.000551	CcSEcCtD
Mefenamic acid—Diarrhoea—Docetaxel—pancreatic cancer	0.000109	0.000551	CcSEcCtD
Mefenamic acid—Confusional state—Epirubicin—pancreatic cancer	0.000108	0.000548	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—pancreatic cancer	0.000108	0.000544	CcSEcCtD
Mefenamic acid—Oedema—Epirubicin—pancreatic cancer	0.000107	0.000543	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000107	0.000543	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000107	0.000541	CcSEcCtD
Mefenamic acid—Infection—Epirubicin—pancreatic cancer	0.000107	0.00054	CcSEcCtD
Mefenamic acid—Shock—Epirubicin—pancreatic cancer	0.000106	0.000534	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—pancreatic cancer	0.000106	0.000533	CcSEcCtD
Mefenamic acid—Dizziness—Docetaxel—pancreatic cancer	0.000105	0.000532	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000105	0.000532	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—pancreatic cancer	0.000105	0.000532	CcSEcCtD
Mefenamic acid—Tachycardia—Epirubicin—pancreatic cancer	0.000105	0.00053	CcSEcCtD
Mefenamic acid—Skin disorder—Epirubicin—pancreatic cancer	0.000104	0.000528	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—pancreatic cancer	0.000103	0.000522	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000103	0.000521	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—pancreatic cancer	0.000103	0.000518	CcSEcCtD
Mefenamic acid—Anorexia—Epirubicin—pancreatic cancer	0.000102	0.000518	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—pancreatic cancer	0.000101	0.000513	CcSEcCtD
Mefenamic acid—Vomiting—Docetaxel—pancreatic cancer	0.000101	0.000512	CcSEcCtD
Mefenamic acid—Rash—Docetaxel—pancreatic cancer	0.0001	0.000508	CcSEcCtD
Mefenamic acid—Hypotension—Epirubicin—pancreatic cancer	0.0001	0.000507	CcSEcCtD
Mefenamic acid—Dermatitis—Docetaxel—pancreatic cancer	0.0001	0.000507	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—pancreatic cancer	0.0001	0.000507	CcSEcCtD
Mefenamic acid—Headache—Docetaxel—pancreatic cancer	9.98e-05	0.000504	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—pancreatic cancer	9.95e-05	0.000503	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.95e-05	0.000503	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—pancreatic cancer	9.88e-05	0.000499	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—pancreatic cancer	9.79e-05	0.000494	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.74e-05	0.000492	CcSEcCtD
Mefenamic acid—Insomnia—Epirubicin—pancreatic cancer	9.72e-05	0.000491	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—pancreatic cancer	9.71e-05	0.00049	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—pancreatic cancer	9.66e-05	0.000488	CcSEcCtD
Mefenamic acid—Paraesthesia—Epirubicin—pancreatic cancer	9.65e-05	0.000488	CcSEcCtD
Mefenamic acid—Dyspnoea—Epirubicin—pancreatic cancer	9.58e-05	0.000484	CcSEcCtD
Mefenamic acid—Somnolence—Epirubicin—pancreatic cancer	9.56e-05	0.000483	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—pancreatic cancer	9.48e-05	0.000479	CcSEcCtD
Mefenamic acid—Nausea—Docetaxel—pancreatic cancer	9.47e-05	0.000478	CcSEcCtD
Mefenamic acid—Dyspepsia—Epirubicin—pancreatic cancer	9.46e-05	0.000478	CcSEcCtD
Mefenamic acid—Decreased appetite—Epirubicin—pancreatic cancer	9.34e-05	0.000472	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—pancreatic cancer	9.29e-05	0.00047	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.28e-05	0.000469	CcSEcCtD
Mefenamic acid—Constipation—Epirubicin—pancreatic cancer	9.19e-05	0.000464	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—pancreatic cancer	9e-05	0.000455	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—pancreatic cancer	8.93e-05	0.000451	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—pancreatic cancer	8.87e-05	0.000448	CcSEcCtD
Mefenamic acid—Feeling abnormal—Epirubicin—pancreatic cancer	8.86e-05	0.000448	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—pancreatic cancer	8.84e-05	0.000447	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.79e-05	0.000444	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—pancreatic cancer	8.75e-05	0.000442	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—pancreatic cancer	8.65e-05	0.000437	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.59e-05	0.000434	CcSEcCtD
Mefenamic acid—Urticaria—Epirubicin—pancreatic cancer	8.54e-05	0.000431	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—pancreatic cancer	8.51e-05	0.00043	CcSEcCtD
Mefenamic acid—Abdominal pain—Epirubicin—pancreatic cancer	8.5e-05	0.000429	CcSEcCtD
Mefenamic acid—Body temperature increased—Epirubicin—pancreatic cancer	8.5e-05	0.000429	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—pancreatic cancer	8.2e-05	0.000414	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.13e-05	0.000411	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—pancreatic cancer	7.9e-05	0.000399	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—pancreatic cancer	7.86e-05	0.000397	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—pancreatic cancer	7.86e-05	0.000397	CcSEcCtD
Mefenamic acid—Asthenia—Epirubicin—pancreatic cancer	7.71e-05	0.00039	CcSEcCtD
Mefenamic acid—Pruritus—Epirubicin—pancreatic cancer	7.6e-05	0.000384	CcSEcCtD
Mefenamic acid—Diarrhoea—Epirubicin—pancreatic cancer	7.35e-05	0.000372	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—pancreatic cancer	7.14e-05	0.000361	CcSEcCtD
Mefenamic acid—Dizziness—Epirubicin—pancreatic cancer	7.11e-05	0.000359	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—pancreatic cancer	7.04e-05	0.000356	CcSEcCtD
Mefenamic acid—Vomiting—Epirubicin—pancreatic cancer	6.83e-05	0.000345	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—pancreatic cancer	6.81e-05	0.000344	CcSEcCtD
Mefenamic acid—Rash—Epirubicin—pancreatic cancer	6.78e-05	0.000342	CcSEcCtD
Mefenamic acid—Dermatitis—Epirubicin—pancreatic cancer	6.77e-05	0.000342	CcSEcCtD
Mefenamic acid—Headache—Epirubicin—pancreatic cancer	6.73e-05	0.00034	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—pancreatic cancer	6.58e-05	0.000332	CcSEcCtD
Mefenamic acid—Nausea—Epirubicin—pancreatic cancer	6.38e-05	0.000323	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—pancreatic cancer	6.32e-05	0.00032	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—pancreatic cancer	6.27e-05	0.000317	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—pancreatic cancer	6.27e-05	0.000317	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—pancreatic cancer	6.23e-05	0.000315	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—pancreatic cancer	5.91e-05	0.000298	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—NOTCH1—pancreatic cancer	2.05e-05	0.00097	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.04e-05	0.000963	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—DTX4—pancreatic cancer	2.01e-05	0.000949	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CG—pancreatic cancer	2.01e-05	0.000948	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	1.99e-05	0.000942	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.99e-05	0.000939	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGF—pancreatic cancer	1.98e-05	0.000937	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOTCH1—pancreatic cancer	1.97e-05	0.000932	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPP2R5B—pancreatic cancer	1.95e-05	0.000924	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CTNNB1—pancreatic cancer	1.95e-05	0.00092	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ARG2—pancreatic cancer	1.92e-05	0.00091	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGF—pancreatic cancer	1.91e-05	0.000901	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTEN—pancreatic cancer	1.9e-05	0.000897	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HEY2—pancreatic cancer	1.88e-05	0.000889	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SMAD4—pancreatic cancer	1.87e-05	0.000885	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.84e-05	0.000871	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CB—pancreatic cancer	1.84e-05	0.000869	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HES1—pancreatic cancer	1.83e-05	0.000864	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—pancreatic cancer	1.82e-05	0.000861	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.81e-05	0.000854	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.79e-05	0.000848	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—APOE—pancreatic cancer	1.79e-05	0.000846	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CD—pancreatic cancer	1.76e-05	0.000834	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SRC—pancreatic cancer	1.76e-05	0.000832	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.75e-05	0.000827	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HEY1—pancreatic cancer	1.74e-05	0.000823	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GLP1R—pancreatic cancer	1.71e-05	0.000807	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—pancreatic cancer	1.7e-05	0.000802	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CD—pancreatic cancer	1.69e-05	0.000801	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.69e-05	0.0008	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NRAS—pancreatic cancer	1.69e-05	0.0008	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMP—pancreatic cancer	1.68e-05	0.000795	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—DPYD—pancreatic cancer	1.68e-05	0.000794	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.65e-05	0.00078	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.65e-05	0.000778	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.61e-05	0.000763	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CG—pancreatic cancer	1.61e-05	0.000763	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TERT—pancreatic cancer	1.6e-05	0.000757	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC2A2—pancreatic cancer	1.59e-05	0.000754	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTEN—pancreatic cancer	1.59e-05	0.000751	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.58e-05	0.000746	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—pancreatic cancer	1.58e-05	0.000745	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—pancreatic cancer	1.57e-05	0.000743	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.57e-05	0.00074	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—pancreatic cancer	1.56e-05	0.000737	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JAG2—pancreatic cancer	1.54e-05	0.00073	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—pancreatic cancer	1.54e-05	0.000729	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.54e-05	0.000727	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CB—pancreatic cancer	1.54e-05	0.000727	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HIF1A—pancreatic cancer	1.53e-05	0.000724	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TSC2—pancreatic cancer	1.53e-05	0.000723	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—pancreatic cancer	1.53e-05	0.000722	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.53e-05	0.000721	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.52e-05	0.00072	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MEN1—pancreatic cancer	1.52e-05	0.00072	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A2—pancreatic cancer	1.51e-05	0.000714	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—pancreatic cancer	1.5e-05	0.000707	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—pancreatic cancer	1.48e-05	0.000698	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CB—pancreatic cancer	1.48e-05	0.000698	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.47e-05	0.000695	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KDR—pancreatic cancer	1.47e-05	0.000693	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—pancreatic cancer	1.46e-05	0.000692	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—pancreatic cancer	1.46e-05	0.000689	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SHH—pancreatic cancer	1.45e-05	0.000686	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IAPP—pancreatic cancer	1.43e-05	0.000678	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CD—pancreatic cancer	1.42e-05	0.000671	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—pancreatic cancer	1.41e-05	0.000668	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.4e-05	0.000662	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NFKBIA—pancreatic cancer	1.39e-05	0.000659	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.39e-05	0.000656	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.39e-05	0.000656	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH1—pancreatic cancer	1.38e-05	0.000653	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HSPA1B—pancreatic cancer	1.38e-05	0.000651	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—pancreatic cancer	1.38e-05	0.000651	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.37e-05	0.000647	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CTNNB1—pancreatic cancer	1.36e-05	0.000644	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GLP1R—pancreatic cancer	1.36e-05	0.000641	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.36e-05	0.000641	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CG—pancreatic cancer	1.35e-05	0.000638	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—pancreatic cancer	1.34e-05	0.000633	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—pancreatic cancer	1.34e-05	0.000632	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGF—pancreatic cancer	1.33e-05	0.000631	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—DPYD—pancreatic cancer	1.33e-05	0.000631	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTEN—pancreatic cancer	1.33e-05	0.000628	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CTNNB1—pancreatic cancer	1.31e-05	0.000619	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTEN—pancreatic cancer	1.28e-05	0.000603	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.27e-05	0.000602	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A2—pancreatic cancer	1.27e-05	0.000598	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.25e-05	0.000592	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—pancreatic cancer	1.25e-05	0.00059	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HRAS—pancreatic cancer	1.24e-05	0.000585	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CB—pancreatic cancer	1.24e-05	0.000585	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CD44—pancreatic cancer	1.23e-05	0.000584	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JAG1—pancreatic cancer	1.23e-05	0.000582	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SRC—pancreatic cancer	1.23e-05	0.000582	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—pancreatic cancer	1.23e-05	0.000579	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.21e-05	0.000572	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.21e-05	0.000572	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—pancreatic cancer	1.2e-05	0.000567	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.2e-05	0.000566	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—pancreatic cancer	1.19e-05	0.000562	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CD—pancreatic cancer	1.19e-05	0.000561	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NRAS—pancreatic cancer	1.19e-05	0.00056	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GCG—pancreatic cancer	1.18e-05	0.00056	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SRC—pancreatic cancer	1.18e-05	0.00056	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD44—pancreatic cancer	1.17e-05	0.000553	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HSPA1A—pancreatic cancer	1.16e-05	0.000549	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.14e-05	0.000541	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—pancreatic cancer	1.14e-05	0.00054	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NRAS—pancreatic cancer	1.14e-05	0.000538	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.13e-05	0.000534	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—pancreatic cancer	1.12e-05	0.00053	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.11e-05	0.000527	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—STK11—pancreatic cancer	1.11e-05	0.000526	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—pancreatic cancer	1.1e-05	0.000522	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.1e-05	0.000522	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—pancreatic cancer	1.1e-05	0.000521	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.1e-05	0.000521	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—pancreatic cancer	1.09e-05	0.000517	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.09e-05	0.000513	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—pancreatic cancer	1.08e-05	0.00051	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTEN—pancreatic cancer	1.07e-05	0.000505	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—pancreatic cancer	1.06e-05	0.000501	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—pancreatic cancer	1.06e-05	0.0005	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.04e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—pancreatic cancer	1.04e-05	0.00049	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CB—pancreatic cancer	1.03e-05	0.000489	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.03e-05	0.000487	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—pancreatic cancer	1.02e-05	0.000482	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.02e-05	0.000482	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—pancreatic cancer	9.94e-06	0.00047	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.84e-06	0.000465	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CD44—pancreatic cancer	9.8e-06	0.000463	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—pancreatic cancer	9.8e-06	0.000463	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.6e-06	0.000454	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMS—pancreatic cancer	9.58e-06	0.000453	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—pancreatic cancer	9.52e-06	0.00045	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GCG—pancreatic cancer	9.4e-06	0.000444	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—pancreatic cancer	9.37e-06	0.000443	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—pancreatic cancer	9.26e-06	0.000438	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SMAD4—pancreatic cancer	9.24e-06	0.000437	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.19e-06	0.000435	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CTNNB1—pancreatic cancer	9.17e-06	0.000434	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—pancreatic cancer	9.16e-06	0.000433	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—pancreatic cancer	9.07e-06	0.000429	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HES1—pancreatic cancer	9.02e-06	0.000427	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—pancreatic cancer	9.01e-06	0.000426	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—pancreatic cancer	8.99e-06	0.000425	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.98e-06	0.000424	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.96e-06	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTEN—pancreatic cancer	8.94e-06	0.000423	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—STK11—pancreatic cancer	8.84e-06	0.000418	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—DPYD—pancreatic cancer	8.83e-06	0.000418	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HRAS—pancreatic cancer	8.67e-06	0.00041	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	8.38e-06	0.000396	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HRAS—pancreatic cancer	8.33e-06	0.000394	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.3e-06	0.000392	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.3e-06	0.000392	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SRC—pancreatic cancer	8.29e-06	0.000392	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—pancreatic cancer	8.07e-06	0.000382	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.01e-06	0.000378	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—pancreatic cancer	8e-06	0.000378	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CD44—pancreatic cancer	7.98e-06	0.000377	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NRAS—pancreatic cancer	7.98e-06	0.000377	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TERT—pancreatic cancer	7.91e-06	0.000374	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.81e-06	0.000369	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—pancreatic cancer	7.79e-06	0.000368	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.74e-06	0.000366	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—pancreatic cancer	7.66e-06	0.000362	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GCG—pancreatic cancer	7.65e-06	0.000361	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMS—pancreatic cancer	7.6e-06	0.000359	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIF1A—pancreatic cancer	7.56e-06	0.000357	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TSC2—pancreatic cancer	7.54e-06	0.000357	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—pancreatic cancer	7.54e-06	0.000356	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—pancreatic cancer	7.43e-06	0.000351	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—pancreatic cancer	7.41e-06	0.00035	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—pancreatic cancer	7.38e-06	0.000349	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.37e-06	0.000348	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—pancreatic cancer	7.36e-06	0.000348	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.29e-06	0.000345	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—pancreatic cancer	7.27e-06	0.000343	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—STK11—pancreatic cancer	7.19e-06	0.00034	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CG—pancreatic cancer	7.03e-06	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—pancreatic cancer	6.86e-06	0.000324	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOTCH1—pancreatic cancer	6.81e-06	0.000322	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—pancreatic cancer	6.78e-06	0.000321	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.75e-06	0.000319	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGF—pancreatic cancer	6.59e-06	0.000311	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CD44—pancreatic cancer	6.49e-06	0.000307	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.36e-06	0.0003	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—pancreatic cancer	6.31e-06	0.000298	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.3e-06	0.000298	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GCG—pancreatic cancer	6.22e-06	0.000294	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.19e-06	0.000292	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—pancreatic cancer	6.18e-06	0.000292	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CD—pancreatic cancer	6.18e-06	0.000292	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—pancreatic cancer	6.16e-06	0.000291	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—pancreatic cancer	6.1e-06	0.000288	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CD—pancreatic cancer	5.86e-06	0.000277	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—STK11—pancreatic cancer	5.85e-06	0.000277	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.85e-06	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HRAS—pancreatic cancer	5.83e-06	0.000276	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CG—pancreatic cancer	5.58e-06	0.000264	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.49e-06	0.00026	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CB—pancreatic cancer	5.39e-06	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—pancreatic cancer	5.38e-06	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—pancreatic cancer	5.34e-06	0.000252	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—pancreatic cancer	5.15e-06	0.000244	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CB—pancreatic cancer	5.1e-06	0.000241	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.03e-06	0.000238	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—pancreatic cancer	5.03e-06	0.000238	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CD—pancreatic cancer	4.9e-06	0.000232	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.76e-06	0.000225	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTEN—pancreatic cancer	4.65e-06	0.00022	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.54e-06	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CTNNB1—pancreatic cancer	4.53e-06	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTEN—pancreatic cancer	4.41e-06	0.000209	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.38e-06	0.000207	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CB—pancreatic cancer	4.28e-06	0.000202	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—pancreatic cancer	4.09e-06	0.000194	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SRC—pancreatic cancer	4.09e-06	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.99e-06	0.000189	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—pancreatic cancer	3.95e-06	0.000186	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NRAS—pancreatic cancer	3.94e-06	0.000186	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.88e-06	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.69e-06	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTEN—pancreatic cancer	3.69e-06	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—pancreatic cancer	3.67e-06	0.000173	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—pancreatic cancer	3.66e-06	0.000173	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—pancreatic cancer	3.59e-06	0.000169	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.57e-06	0.000169	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.48e-06	0.000164	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.45e-06	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—pancreatic cancer	3.39e-06	0.00016	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—pancreatic cancer	3.28e-06	0.000155	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.25e-06	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—pancreatic cancer	3.11e-06	0.000147	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.01e-06	0.000142	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HRAS—pancreatic cancer	2.88e-06	0.000136	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.83e-06	0.000134	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.81e-06	0.000133	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—pancreatic cancer	2.68e-06	0.000127	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—pancreatic cancer	2.61e-06	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—pancreatic cancer	2.54e-06	0.00012	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.45e-06	0.000116	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—pancreatic cancer	2.13e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.12e-06	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.73e-06	8.19e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	8.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.41e-06	6.66e-05	CbGpPWpGaD
